SCHEMBL7659831

SCHEMBL7659831

CCCCC(NC(=O)c1ccccc1Oc1ccccc1)C(=O)CNC(C)=O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.48
L3MBTL1 Q9Y468 4/20 0.47
NPSR1 Q6W5P4 2/20 0.47
ICMT O60725 4/20 0.45
LMNA P02545 1/20 0.44
MAPT P10636 1/20 0.44
ALDH1A1 P00352 2/20 0.43
ATM Q13315 2/20 0.43
MAPK8 P45983 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
GAA P10253 1/20 0.43
HPGD P15428 1/20 0.43
HTT P42858 1/20 0.43
RAB9A P51151 1/20 0.43
C3AR1 Q16581 1/20 0.42
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
POLB P06746 1/20 0.42
FOLH1 Q04609 1/20 0.41
PPARA Q07869 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7666903 0.90 KDM4E (0.47) KDM4EL3MBTL1NPSR1ICMTLMNA
SCHEMBL7694696 0.86 KDM4E (0.47) KDM4EL3MBTL1NPSR1ICMTALDH1A1
SCHEMBL7421842 0.85 L3MBTL1 (0.46) KDM4EL3MBTL1NPSR1ICMTLMNA
SCHEMBL7675029 0.83 L3MBTL1 (0.44) KDM4EL3MBTL1NPSR1ICMTLMNA
SCHEMBL7657278 0.83 CLPP (0.44) NPSR1LMNAHTTMEN1KMT2A
SCHEMBL7696167 0.79 CAPN1 (0.57)
SCHEMBL7390854 0.75 KDM4E (0.55) KDM4EL3MBTL1NPSR1ICMTLMNA
SCHEMBL7694147 0.75 ACE (0.46) KDM4EL3MBTL1NPSR1LMNAALDH1A1
SCHEMBL7696690 0.74 CAPN1 (0.54)
SCHEMBL7696610 0.74 CAPN1 (0.58) KDM4EL3MBTL1LMNAMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6436925-B1 BETTER ABLE TO CROSS MEMBRANES; INHIBITORS OF CYSTEINE PROTEASES LIKE CALPAIN I AND II AND CATHEPSIN B AND L, CAN THUS BE USED TO CONTROL DISEASES ASSOCIATED WITH AN ELEVATED ACTIVITY OF CALPAIN ENZYMES OR CATHEPSIN ENZYMES ABBOTT LABORATORIES 2002-08-20 US disclosed